Related Experiment Video
Updated: Dec 8, 2025

10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
4.2K
A Comprehensive Study on Aptasensors For Cancer Diagnosis
Sambhavi Animesh1, Yengkhom D Singh2
1Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, 781039, India.
Current Pharmaceutical Biotechnology
|September 22, 2020
Summary
Aptasensors, which use aptamers as molecular probes, offer a highly sensitive and specific method for early cancer detection. These novel biosensing platforms are paving the way for advanced point-of-care cancer diagnostics.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Cancer Research
Background:
- Cancer remains a leading cause of mortality worldwide, underscoring the critical need for early detection and diagnosis.
- Current diagnostic methods face challenges in achieving rapid and efficient cancer cell identification at early stages.
- Aptamers, functional nucleic acid analogues, offer high specificity and sensitivity for detecting cancer biomarkers and rare circulating tumor cells.
Purpose of the Study:
- To review newly developed aptasensors for cancer diagnostics.
- To highlight the potential of aptasensors in improving early cancer detection and point-of-care testing.
Main Methods:
- Focuses on a comprehensive review of recent advancements in aptasensor technology for cancer diagnosis.
- Explores the integration of aptamers with various biosensing platforms.
Main Results:
- Aptasensors demonstrate significant potential for highly specific and sensitive detection of cancer biomarkers and circulating tumor cells.
- The development of aptasensors facilitates promising new avenues for point-of-care cancer diagnostics.
Conclusions:
- Aptasensors represent a significant advancement in molecular diagnostics for cancer.
- The high sensitivity and specificity of aptasensors pave the way for improved early cancer detection and patient outcomes.

